
|Articles|January 3, 2022
Pharmacy Clinical Pearl of the Day: Gaucher Disease
Author(s)Saro Arakelians, PharmD
Symptoms of Gaucher disease include abdominal complaints, skeletal abnormalities, and blood disorders.
Advertisement
Clinical Pearl of the Day:Gaucher’s disease
Gaucher disease is the result of a buildup of certain fatty substances in certain organs, particularly the spleen and liver.
Insight:
- The fatty substances also can build up in bone tissue, weakening the bone and increasing the risk of fractures.
 - If the bone marrow is affected, it can interfere with the blood's ability to clot.
 - Symptoms include abdominal complaints, skeletal abnormalities, and blood disorders.
 - Causes include hereditary history in the parents of the patient.
 - Risk factors include Eastern and Central European Jewish ancestry.
 - Diagnosis includes physical exam, lab tests, and imaging studies.
 - Treatment includes enzyme replacement therapies, miglustat (Zavesca), eliglustat (Cerdelga), and osteoporosis drugs.
 
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
RSV May Complicate Multiple Myeloma Care Through Therapy Delays, Not Mortality Risk
5














































































































































































































